scispace - formally typeset
Search or ask a question

Showing papers by "Henry Buchwald published in 1987"


Patent
02 Feb 1987
TL;DR: A flexible spring diaphragm (25) forms an outer back wall portion (26) of a housing (22) of an implantable infusion pump (20) for infusing drugs or other chemicals or solutions into the body as discussed by the authors.
Abstract: An implantable infusion pump (20) for infusing drugs or other chemicals or solutions into the body. A flexible spring diaphragm (25) forms an outer back wall portion (26) of a housing (22) of the infusion pump (20). The spring diaphragm (25) applies substantially constant force over a range of displacement and communicating internal body pressure to the drug chamber (30) so as to maintain a substantially uniform pressure difference between the drug chamber (30) and the internal body pressure.

144 citations


Patent
02 Feb 1987
TL;DR: An implantable infusion pump (20) for infusing drugs or other chemical or solutions into the body is described in this paper, where a movable diaphragm (26) forming a variable volume drug chamber and a fluid piston (32) opposing the force exerted by the diaphrasm on the drug solution in the drug chamber are presented.
Abstract: An implantable infusion pump (20) for infusing drugs or other chemical or solutions into the body. A movable diaphragm (26) forming a variable volume drug chamber (22). A fluid piston (32) opposing the force exerted by the diaphragm (26) on the drug solution in the drug chamber (22). The pressure of the fluid piston (32) being controlled by a regulator (33) providing a reference pressure and in fluid communication with the fluid piston (32). The regulator (33) reducing the fluid pressure of the piston fluid (32) as drug solution is expelled from the drug chamber (22) so as to maintain a constant pressure differential between the drug chamber (22) and an infusion site in the body. The implantable infusion pump (20) being readily adaptable to variable or electronic flow control.

91 citations


Journal ArticleDOI
TL;DR: The Program on Surgical Control of the Hyperlipidemias (POSCH) is an investigator-initiated NHLBI grant-funded secondary coronary heart disease intervention trial using partial ileal bypass (PIB) for lipid reduction.

27 citations


Journal Article
01 Jan 1987-Surgery
TL;DR: These lipoprotein changes are greater than have been reported from any previous trial of dietary or pharmacologic intervention, including the Lipid Research Clinics-Coronary Primary Prevention Trial, which used cholestyramine.

19 citations


Journal Article
01 Jul 1987-Surgery
TL;DR: Alfalfa is an effective adjuvant to PIB for reducing total and lipoprotein C fractions and thereby suppresses, in part, the physiologic rebound effect of PIB surgery by increasing hepatic C and NSL synthesis; inversely, P IB surgery inhibits the additive effect in the liver synthesis of FA produced by alfalfA.

7 citations




Journal Article
TL;DR: A surgical technique for implanting a readily available, human-sized drug infusion pump in rabbits, which can be of particular importance in the study of atherosclerosis where the dog is a poor model and the rabbit an excellent one is developed.
Abstract: This paper describes a surgical technique for implanting a readily available, human-sized drug infusion pump in rabbits. We developed this technique in order to expand uses of implantable infusion pump technology in the laboratory. The dog, which has been the research animal of choice in previous studies using implantable pumps, can now be replaced by smaller, less expensive animals for similar or other laboratory purposes. This technique can be of particular importance in the study of atherosclerosis where the dog is a poor model and the rabbit an excellent one. In 18 rabbits with inferior vena cava cannulations, we were able to obtain 100% survival and constant solution delivery for up to and greater than 6 months. This technique is safe and reproducible. By employing a simple catheter modification and using special pump anchoring precautions, we found that we could successfully use a human-sized device in rabbit studies. Commentary is also made concerning the relative contributions to patency and vein sclerosis of catheter diameter and the infusate media.

2 citations